Skip to main content
SpringerLink
Log in

Glycosaminoglycans Excretion in Interstitial Cystitis

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Glycosaminoglycans (GAGs) have been identified histochemically and biochemically in urothelium. They have been suggested to have an anti-adherence effect at the bladder surface important in the urothelial defence against bacterial and carcinogenic insult. The aim of this study was to investigate urinary GAGs excretion in patients with interstitial cystitis.

Urinary GAG excretion was determined in patients with interstitial cystitis (n:34; 16 males, 18 females) and healthy subjects (n:34; 16 males, 18 females). Urinary GAG determinations were made by the dimethymethylene blue method. Student's t-test was used for statistical analysis of the results.

Urinary GAG excretion was found to be elevated significantly in patients with interstitial cystitis (14.45±2.02 mg/g Cr) as compared to healthy subjects (10.11±2.3 mg/g Cr) (p<0.01). There was no significant difference in urinary GAG excretion between males and females in either the healthy subjects or in the patients.

Determination of urinary GAG excretion may be an important non-invasive test in the investigation of patients with interstitial cystitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Thorone, I. D., Resnick, M. I.: A methodology for the characterisation of urinary glycosaminoglycans. J. Urol., 13, 995 (1984).

    Google Scholar 

  2. Lilly, L. D., Parson, C. L.: Bladder surface glycosaminoglycan is a human epithelial permeability barrier. Surg. Gynec., 171, 493 (1990).

    Google Scholar 

  3. Hurst, R. E., Parson, C. L., Roy, J. B.: Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis. J. Urol., 149, 31 (1993).

    Google Scholar 

  4. Gambaro, G., Cicerello, S., Mastrosimone, G., Lawagnim, T., Baggio, B.: High urinary excretion of glycosaminoglycans. A possible marker of glomerular involvement in diabetes. Metabolism, 38, 419 (1989).

    Google Scholar 

  5. Nesse, A., Garbossa, G., Romero, M. C., Bogado, C. E., Zanchetta, J. R.: Glycosaminoglycans in urolithiasis. Nephron, 62, 36 (1992).

    Google Scholar 

  6. Mitsuhaski, H., Tsukada, Y., Ono, K., Yano, S., Naruse, T.: Urine glycosaminoglycans and neparan sulphate excretions in adult patients with glomerular diseases. Clin. Nephrology, 39, 231 (1993).

    Google Scholar 

  7. Konukoğlu, D., Akçay, T., Erözenci, A.: The importance of urinary glycosaminoglycan as a marker for superficial bladder tumors. Cancer Biochem. Biophys., 15, 91 (1995).

    Google Scholar 

  8. Parsons, C. L., Schmidt, J. D., Pollen, J. J.: Successful treatment of interstitial cystitis with sodium pentosanpolysulphate. J. Urol., 130, 51 (1983).

    Google Scholar 

  9. Gillenwater, J. Y., Wein, A. J.: Summary of the national institute of arthritis, diabetes, digestive and kidney diseases workshop on interstitial cystitis, National Institute of Health. J. Urol., 140, 203 (1988).

    Google Scholar 

  10. Pain, G., Naia, S., Dall'Amico, R., Chandetti, L., Zachello, E. E., Catassi, C.: Simple spectrophotometric quantification of urinary excretion of glycosaminoglycan sulphates. Clin. Chem., 32, 2073 (1986).

    Google Scholar 

  11. Goldberg, J. M., Cotlier, E.: Specific isolation and analysis of mucopolysaccharides (Glycosaminoglycan) from human urine. Clin. Chem. Acta, 41, 19 (1984).

    Google Scholar 

  12. Parsons, C. L., Greenspan, C., Mulholland, S. G.: The primary antibacterial defense mechanism of the bladder. Invest Urol., 13, 72 (1975).

    Google Scholar 

  13. Baggio, B., Gambaro, G., Cicerello, S., Mastrosimone, G., Manzaro, A., Pagano, F.: Urinary excretion of glycosaminoglycans in urological disease. Clin. Biochem., 20, 449 (1987).

    Google Scholar 

  14. Fellstrom, B., Danielson, B. G., Ljunghall, S., Wirkstrom, B.: Combined enzymatic degradation with chondroitinase and Alcian Blue precipitation in determination of urinary chondroit in sulphates. Urol. Res., 12, 91 (1981).

    Google Scholar 

  15. Whitley, C. P., Rdmour, M. D., Draper, K. A., Dutton, C. M., Negila, J. P.: Diagnostic test for mucopolysaccharidoses. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion. Clin. Chem., 35, 374 (1989).

    Google Scholar 

  16. Pennock, C. A.: A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion in the diagnosis of the mucopolysaccharidoses. J. Clin. Path., 29, 111 (1976).

    Google Scholar 

  17. Hesse, A., Wuzel, H., Vahlensieck, W.: The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons. Urology, 41, 81 (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Istanbul University, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey

    T. Akçay & D. Konukoğlu

Authors
  1. T. Akçay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Konukoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akçay, T., Konukoğlu, D. Glycosaminoglycans Excretion in Interstitial Cystitis. Int Urol Nephrol 31, 431–435 (1999). https://doi.org/10.1023/A:1007198708404

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007198708404

Keywords

Search

Navigation